The director of the German laboratory BioNTech, which works with the American Pfizer on a vaccine against Covid-19, has estimated the authorization and distribution by the end of the year in the US and Europe as “possible”. “It is a chance because this year we can obtain authorization in the US, in the EU or in both regions”, estimates Ugur Sahi, specifying that the authorization request will be filed tomorrow with the FDA. “It is possible that the first doses will be delivered in December,” he added.
<!–